Performance and Prognostic Relevance of Lymph Node Assessment by One-Step Nucleic Acid Amplification Assay in Rectal Cancer

Background/Objectives: Lymph node metastases (LNM) undetected by standard hematoxylin and eosin (H&E) have been associated with unfavorable prognosis in colorectal cancer. The One-Step Nucleic Acid Amplification (OSNA) assay has demonstrated superior sensitivity in detecting LNM compared to H&E. We...

Descripción completa

Detalles Bibliográficos
Autores: Liu, Qing|||0000-0003-1784-6400; López-Prades, Sandra|||0000-0001-8208-2959; Saez de Gordoa, Karmele|||0000-0001-8106-6121; Rodrigo Calvo, María Teresa|||0000-0001-6675-3425; Garcia Gerona, Mireia|||0000-0003-3445-9744; Ruiz Martin, Juan; Romo-Navarro, Ángel|||0000-0002-7094-8484; Pinilla Pagnon, Ignacio|||0000-0002-6120-8302; Tarragona, Jordi|||0000-0002-1459-4087; Otero Alén, Begoña|||0000-0002-2876-6732; Camps Polo, Jordi|||0000-0003-2929-4228; Archilla, Ivan|||0000-0002-2142-0608; Cuatrecasas, Miriam|||0000-0003-3063-0110
Tipo de documento: Artículo
Fecha de publicación:2025
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Lenguaje:Inglés
OAI Identifier:oai:ddd.uab.cat:318774
Acceso en línea:https://ddd.uab.cat/record/318774
https://dx.doi.org/urn:doi:10.3390/cancers17132141
Nivel de acceso:Acceso abierto
Palabra clave:Rectal carcinoma
Lymph node metastases
Staging
Diagnosis
Prognosis
OSNA
_version_ 1878739989050687488
author Liu, Qing|||0000-0003-1784-6400
author2 López-Prades, Sandra|||0000-0001-8208-2959
Saez de Gordoa, Karmele|||0000-0001-8106-6121
Rodrigo Calvo, María Teresa|||0000-0001-6675-3425
Garcia Gerona, Mireia|||0000-0003-3445-9744
Ruiz Martin, Juan
Romo-Navarro, Ángel|||0000-0002-7094-8484
Pinilla Pagnon, Ignacio|||0000-0002-6120-8302
Tarragona, Jordi|||0000-0002-1459-4087
Otero Alén, Begoña|||0000-0002-2876-6732
Camps Polo, Jordi|||0000-0003-2929-4228
Archilla, Ivan|||0000-0002-2142-0608
Cuatrecasas, Miriam|||0000-0003-3063-0110
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author_browse Archilla, Ivan|||0000-0002-2142-0608
Camps Polo, Jordi|||0000-0003-2929-4228
Cuatrecasas, Miriam|||0000-0003-3063-0110
Garcia Gerona, Mireia|||0000-0003-3445-9744
Liu, Qing|||0000-0003-1784-6400
López-Prades, Sandra|||0000-0001-8208-2959
Otero Alén, Begoña|||0000-0002-2876-6732
Pinilla Pagnon, Ignacio|||0000-0002-6120-8302
Rodrigo Calvo, María Teresa|||0000-0001-6675-3425
Romo-Navarro, Ángel|||0000-0002-7094-8484
Ruiz Martin, Juan
Saez de Gordoa, Karmele|||0000-0001-8106-6121
Tarragona, Jordi|||0000-0002-1459-4087
author_facet Liu, Qing|||0000-0003-1784-6400
López-Prades, Sandra|||0000-0001-8208-2959
Saez de Gordoa, Karmele|||0000-0001-8106-6121
Rodrigo Calvo, María Teresa|||0000-0001-6675-3425
Garcia Gerona, Mireia|||0000-0003-3445-9744
Ruiz Martin, Juan
Romo-Navarro, Ángel|||0000-0002-7094-8484
Pinilla Pagnon, Ignacio|||0000-0002-6120-8302
Tarragona, Jordi|||0000-0002-1459-4087
Otero Alén, Begoña|||0000-0002-2876-6732
Camps Polo, Jordi|||0000-0003-2929-4228
Archilla, Ivan|||0000-0002-2142-0608
Cuatrecasas, Miriam|||0000-0003-3063-0110
author_role author
collection Dipòsit Digital de Documents de la UAB
description Background/Objectives: Lymph node metastases (LNM) undetected by standard hematoxylin and eosin (H&E) have been associated with unfavorable prognosis in colorectal cancer. The One-Step Nucleic Acid Amplification (OSNA) assay has demonstrated superior sensitivity in detecting LNM compared to H&E. We aimed to assess the performance of OSNA in detecting LNM, as well as its prognostic value in rectal cancer (RC) patients. Methods: Lymph nodes (LNs) of patients from 15 centers were analyzed by both H&E and OSNA. The total tumor load (TTL) was defined as the sum of cytokeratin 19 mRNA copies/µL in all LNs from a surgical specimen, using a threshold of 250 copies/μL for OSNA positivity. Cox proportional hazard regression was used to assess the effect of TTL ≥ 250 or 6000 copies/μL on cancer-specific survival (CSS) and recurrence-free survival (RFS), with Firth's method applied to account for low event rate. Results: A total of 97 RC patients were included. Of these, 84 patients were eligible for survival analysis. The sensitivity and specificity of OSNA, compared to H&E, were 91.7% and 84.7%, respectively. TTL ≥ 6000 versus <6000 copies/μL was related to worse CSS and RFS. When dividing TTL into three groups: ≤250, 250-6000, and.
eu_rights_str_mv openAccess
format article
id ES_cbb1d2e54d3945a3a0c4b686accada1f
institution Universitat Autònoma de Barcelona
instname_str Universitat Autònoma de Barcelona
language eng
network_acronym_str ES
network_name_str España
oai_identifier_str oai:ddd.uab.cat:318774
publishDate 2025
publishDateSort 2025
reponame_str Dipòsit Digital de Documents de la UAB
spelling Performance and Prognostic Relevance of Lymph Node Assessment by One-Step Nucleic Acid Amplification Assay in Rectal Cancer A Multicenter Study Liu, Qing|||0000-0003-1784-6400 López-Prades, Sandra|||0000-0001-8208-2959 Saez de Gordoa, Karmele|||0000-0001-8106-6121 Rodrigo Calvo, María Teresa|||0000-0001-6675-3425 Garcia Gerona, Mireia|||0000-0003-3445-9744 Ruiz Martin, Juan Romo-Navarro, Ángel|||0000-0002-7094-8484 Pinilla Pagnon, Ignacio|||0000-0002-6120-8302 Tarragona, Jordi|||0000-0002-1459-4087 Otero Alén, Begoña|||0000-0002-2876-6732 Camps Polo, Jordi|||0000-0003-2929-4228 Archilla, Ivan|||0000-0002-2142-0608 Cuatrecasas, Miriam|||0000-0003-3063-0110 Rectal carcinoma Lymph node metastases Staging Diagnosis Prognosis OSNA Background/Objectives: Lymph node metastases (LNM) undetected by standard hematoxylin and eosin (H&E) have been associated with unfavorable prognosis in colorectal cancer. The One-Step Nucleic Acid Amplification (OSNA) assay has demonstrated superior sensitivity in detecting LNM compared to H&E. We aimed to assess the performance of OSNA in detecting LNM, as well as its prognostic value in rectal cancer (RC) patients. Methods: Lymph nodes (LNs) of patients from 15 centers were analyzed by both H&E and OSNA. The total tumor load (TTL) was defined as the sum of cytokeratin 19 mRNA copies/µL in all LNs from a surgical specimen, using a threshold of 250 copies/μL for OSNA positivity. Cox proportional hazard regression was used to assess the effect of TTL ≥ 250 or 6000 copies/μL on cancer-specific survival (CSS) and recurrence-free survival (RFS), with Firth's method applied to account for low event rate. Results: A total of 97 RC patients were included. Of these, 84 patients were eligible for survival analysis. The sensitivity and specificity of OSNA, compared to H&E, were 91.7% and 84.7%, respectively. TTL ≥ 6000 versus <6000 copies/μL was related to worse CSS and RFS. When dividing TTL into three groups: ≤250, 250-6000, and. https://ddd.uab.cat/record/318774 https://dx.doi.org/urn:doi:10.3390/cancers17132141
spellingShingle Performance and Prognostic Relevance of Lymph Node Assessment by One-Step Nucleic Acid Amplification Assay in Rectal Cancer
Liu, Qing|||0000-0003-1784-6400
Rectal carcinoma
Lymph node metastases
Staging
Diagnosis
Prognosis
OSNA
title Performance and Prognostic Relevance of Lymph Node Assessment by One-Step Nucleic Acid Amplification Assay in Rectal Cancer
title_full Performance and Prognostic Relevance of Lymph Node Assessment by One-Step Nucleic Acid Amplification Assay in Rectal Cancer
title_fullStr Performance and Prognostic Relevance of Lymph Node Assessment by One-Step Nucleic Acid Amplification Assay in Rectal Cancer
title_full_unstemmed Performance and Prognostic Relevance of Lymph Node Assessment by One-Step Nucleic Acid Amplification Assay in Rectal Cancer
title_short Performance and Prognostic Relevance of Lymph Node Assessment by One-Step Nucleic Acid Amplification Assay in Rectal Cancer
title_sort Performance and Prognostic Relevance of Lymph Node Assessment by One-Step Nucleic Acid Amplification Assay in Rectal Cancer
topic Rectal carcinoma
Lymph node metastases
Staging
Diagnosis
Prognosis
OSNA
topic_facet Rectal carcinoma
Lymph node metastases
Staging
Diagnosis
Prognosis
OSNA
url https://ddd.uab.cat/record/318774
https://dx.doi.org/urn:doi:10.3390/cancers17132141